ANI Pharmaceuticals
ANIP
ANIP
265 hedge funds and large institutions have $1.87B invested in ANI Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 62 funds opening new positions, 82 increasing their positions, 82 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more call options, than puts
Call options by funds: $2.87M | Put options by funds: $2.86M
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 82
Holders
265
Holding in Top 10
2
Calls
$2.87M
Puts
$2.86M
Top Buyers
| 1 | +$36.6M | |
| 2 | +$33M | |
| 3 | +$26.5M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$25.3M |
| 5 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$21.5M |
Top Sellers
| 1 | -$86M | |
| 2 | -$24.1M | |
| 3 | -$22.9M | |
| 4 |
GACM
Global Alpha Capital Management
Montreal,
Quebec, Canada
|
-$21.2M |
| 5 |
FGP
Freestone Grove Partners
San Francisco,
California
|
-$15.1M |
